Raymond James Biotech Innovation Symposium: Dyne's CEO John Cox shares an overview of the company's recent landmark DMD data episode artwork

EPISODE · Apr 14, 2026 · 12 MIN

Raymond James Biotech Innovation Symposium: Dyne's CEO John Cox shares an overview of the company's recent landmark DMD data

from BiotechTV - News · host BiotechTV

He describes both the biomarker and functional benefits seen in the December data for the company's next-generation exon 51 skipping therapy.

He describes both the biomarker and functional benefits seen in the December data for the company's next-generation exon 51 skipping therapy.

NOW PLAYING

Raymond James Biotech Innovation Symposium: Dyne's CEO John Cox shares an overview of the company's recent landmark DMD data

0:00 12:58

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of BiotechTV - News?

This episode is 12 minutes long.

When was this BiotechTV - News episode published?

This episode was published on April 14, 2026.

What is this episode about?

He describes both the biomarker and functional benefits seen in the December data for the company's next-generation exon 51 skipping therapy.

Can I download this BiotechTV - News episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!